Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.

Humans Atrial Fibrillation / complications Anticoagulants / therapeutic use Prevalence Administration, Oral Retrospective Studies Heart Atria / diagnostic imaging Atrial Appendage / surgery Heart Diseases / drug therapy Thrombosis / diagnosis Obesity / drug therapy Echocardiography, Transesophageal
Atrial fibrillation NOAC VKA thrombi

Journal

Acta cardiologica
ISSN: 1784-973X
Titre abrégé: Acta Cardiol
Pays: England
ID NLM: 0370570

Informations de publication

Date de publication:
May 2023
Historique:
medline: 11 5 2023
pubmed: 26 11 2021
entrez: 25 11 2021
Statut: ppublish

Résumé

Few data are available regarding the prevalence of left atrium (LA) thrombi in atrial fibrillation (AF) patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). Methods: We evaluated the prevalence and predictors of LA/LA appendage (LAA) thrombi in non-valvular AF patients treated with NOACs referring to a single centre for a scheduled electrical cardioversion (ECV) or catheter ablation (CA). Transesophageal echocardiography (TEE) was performed within 12 h prior to the index procedure. A total of 352 consecutive patients with non-valvular AF treated with NOACs were included in this analysis (ECV group Among real-world patients with non-valvular AF treated with NOACs, we found a high incidence of LA/LAA thrombi compared to previous reports. The main predictors of LA/LAA thrombosis were a CHA

Sections du résumé

BACKGROUND UNASSIGNED
Few data are available regarding the prevalence of left atrium (LA) thrombi in atrial fibrillation (AF) patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). Methods: We evaluated the prevalence and predictors of LA/LA appendage (LAA) thrombi in non-valvular AF patients treated with NOACs referring to a single centre for a scheduled electrical cardioversion (ECV) or catheter ablation (CA). Transesophageal echocardiography (TEE) was performed within 12 h prior to the index procedure.
RESULTS UNASSIGNED
A total of 352 consecutive patients with non-valvular AF treated with NOACs were included in this analysis (ECV group
CONCLUSIONS UNASSIGNED
Among real-world patients with non-valvular AF treated with NOACs, we found a high incidence of LA/LAA thrombi compared to previous reports. The main predictors of LA/LAA thrombosis were a CHA

Identifiants

DOI: 10.1080/00015385.2021.2005307 PMID: 34821203
pubmed: 34821203
doi: 10.1080/00015385.2021.2005307
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

290-297

Auteurs

Filippo Angelini (F)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.
ORCID: 0000-0003-4711-0891

Pier Paolo Bocchino (PP)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Mattia Peyracchia (M)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Andrea Saglietto (A)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Massimo Magnano (M)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.
ORCID: 0000-0002-3531-104X

Nicolò Patanè (N)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Fabrizio D'Ascenzo (F)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Carla Giustetto (C)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Matteo Anselmino (M)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.
ORCID: 0000-0002-6311-4270

Fiorenzo Gaita (F)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Elisabetta Toso (E)

Division of Cardiology, Cardiovascular and Thoracic Department of Medical Sciences, University of Turin and 'Città della Salute e della Scienza' Hospital, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prevalence and predictors of left atrial...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation auriculaire › Prevalence and predictors of left atrial...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Anticoagulants › Prevalence and predictors of left atrial...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › Prevalence and predictors of left atrial...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Voies d'administration de substances chimiques et des médicaments › Administration par voie orale › Prevalence and predictors of left atrial...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Prevalence and predictors of left atrial...
questionsmedicales.fr › Système cardiovasculaire › Coeur › Atrium du coeur › Prevalence and predictors of left atrial...
questionsmedicales.fr › Système cardiovasculaire › Coeur › Atrium du coeur › Auricule de l'atrium › Prevalence and predictors of left atrial...
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › Prevalence and predictors of left atrial...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Embolie et thrombose › Thrombose › Prevalence and predictors of left atrial...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Prevalence and predictors of left atrial...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic cardiovasculaire › Tests de la fonction cardiaque › Échocardiographie › Échocardiographie transoesophagienne › Prevalence and predictors of left atrial...